Neurodegenerative Diseases Related Content
Environmental exposures during early life influence adult disease risk
Carolyn R. Klocke and Pamela J. Lein discuss how an individual’s experiences during early life can influence their risk for disease as an adult.
Researchers discover new genetic brain disease
Manchester researchers have contributed towards the discovery of a genetic brain disease which can cause paraplegia and epilepsy in sufferers.
CBD oil revolution: Introducing what it is and why the hype?
Open Access Government delve into the CBD oil revolution in this introduction to CBD which explores the difference between CBD and THC, as well as a range of benefits and safety precautions for cannabidiol use in cancer patients and pregnant women.
Intramembrane proteases in neurodegenerative diseases
Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.
Supporting vital Alzheimer’s disease research in the U.S and beyond
The work of the National Institute on Aging (NIA) is placed into focus here, with examples of how they are supporting vital Alzheimer’s disease research in the U.S and further afield.
Huntington’s disease (HD): Is there hope on the horizon?
Dr Gerry Morrow shares his thoughts on the rare, progressive neurodegenerative illness, Huntington’s disease (HD).
Five rare diseases you never knew existed
Learn about these five rare diseases to support governments, scientists and healthcare professionals to find treatments.
New treatments for neurodegenerative diseases
Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
UK-Japanese partnership to tackle degenerative diseases
Medical researchers in Britain and Japan are to join forces in the fight to advance research into treatments for degenerative diseases.
Treatment and diagnosis of neurodegenerative disorders
Andrea Varrone studies the importance of molecular imaging to provide personalised medicine and improve care for patients with neurodegenerative disorders
Intramembrane proteases: Regulators of cellular pathways
Prof Dr Regina Fluhrer from Biomedical Center (BMC), Ludwig Maximilians University of Munich (LMU) & German Center for Neurodegenerative Diseases (DZNE) shares her expertise on the field of intramembrane proteases, focussing on regulation of cellular pathways
Tackling neurodegenerative diseases including Alzheimer’s
The work of the EU Joint Programme – Neurodegenerative Disease Research (JPND) which aims to tackle the challenge of these diseases, in particular, Alzheimer’s, is discussed here
Early diagnosis of neurodegenerative disorders: Where are we now?
Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?
Central Auditory Physiology Laboratory
Dr. Sanchez discusses his research into the auditory system in order to develop therapeutic approaches for people with hearing impairment
Neurons within the auditory pathway utilise specialised biophysical properties to precisely encode elements of sound important for normal hearing.
For individuals with hearing impairments – like age-related hearing loss, auditory neuropathy, and central auditory...
A balanced approach to the global challenge of dementia
Dr Yves Joanette, Scientific Director at the CIHR Institute of Aging argues for a balanced approach when it comes to their collaboration-based approach to face the challenge of dementia
Rett syndrome: Research on severe neurodevelopmental disorders
Jennifer J. McComas from the University of Minnesota discusses the current evidence for communication intervention for individuals with Rett syndrome
Neurodegenerative disorders in the U.S.
The vital work of the National Institute on Deafness and Other Communication Disorders (NIDCD) and The National Institute of Neurological Disorders and Stroke (NINDS) are explored here by Open Access Government, with a special focus on neurodegenerative disorders.
Infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease
Tamas Fulop from Université de Sherbrooke’s Research Center on Aging, explains precisely why infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease (AD)
The DZNE: researching neurodegenerative diseases
The DZNE investigates the causes of neurodegenerative diseases and develops novel strategies for prevention, treatment and care.
ALS researchers begin recreating human spinal cords on a chip
NIH-funded study closes in on personalised drug testing for neurological disorders